XML 148 R138.htm IDEA: XBRL DOCUMENT v3.25.0.1
Parent Company Only Financial Statements - Condensed Statements of Cash Flows (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Condensed Financial Statements, Captions [Line Items]      
Net Income (Loss) $ 78,898,000 $ 68,935,000 $ 72,952,000
Depreciation, amortization and accretion, net 20,778,000 14,904,000 15,060,000
Increase in other assets 33,524,000 (20,562,000) (19,537,000)
Increase (decrease) in other liabilities (4,191,000) (1,674,000) 3,318,000
Net cash provided by operating activities 124,425,000 72,417,000 65,824,000
Net cash (used in) provided by investing activities (7,509,000) 474,380,000 (178,688,000)
Proceeds from issuance of common stock 1,054,000 1,004,000 1,244,000
Payment to repurchase common stock (659,000) (465,000) (340,000)
Direct expenses related to capital transactions 0 0 (29,000)
Dividends paid on common stock (22,371,000) (19,557,000) (17,830,000)
Net cash (used in) provided by financing activities (138,764,000) (556,166,000) 96,695,000
Decrease in cash and cash equivalents (21,848,000) (9,369,000) (16,169,000)
Cash and cash equivalents at beginning of period 143,064,000 152,433,000 168,602,000
Cash and cash equivalents at end of period 121,216,000 143,064,000 152,433,000
Parent Company [Member]      
Condensed Financial Statements, Captions [Line Items]      
Net Income (Loss) 78,898,000 68,935,000 72,952,000
Depreciation, amortization and accretion, net 0 265,000 218,000
Dividends received from subsidiary 0 51,213,000 34,040,000
Equity in undistributed earnings of subsidiaries (28,581,000) (26,374,000) (44,811,000)
Increase in other assets (2,221,000) (49,606,000) (208,359,000)
Increase (decrease) in other liabilities (871,000) 1,526,000 (146,000)
Net cash provided by operating activities 47,225,000 45,959,000 (146,106,000)
Investment in subsidiary (4,000,000) 0 0
Net cash from (used in) business acquisition 0 (41,827,000) 67,323,000
Net cash (used in) provided by investing activities (4,000,000) (41,827,000) 67,323,000
Repayment of long-term debt (19,455,000) 0 0
Proceeds from issuance of common stock 1,054,000 1,004,000 93,415,000
Payment to repurchase common stock (659,000) (465,000) (340,000)
Direct expenses related to capital transactions 0 0 (29,000)
Dividends paid on common stock (22,371,000) (19,557,000) (17,830,000)
Net cash (used in) provided by financing activities (41,431,000) (19,018,000) 75,216,000
Decrease in cash and cash equivalents 1,794,000 (14,886,000) (3,567,000)
Cash and cash equivalents at beginning of period 9,968,000 24,854,000 28,421,000
Cash and cash equivalents at end of period $ 11,762,000 $ 9,968,000 $ 24,854,000